Sirona Biochem Corp.
SRBCF · OTC
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | |
|---|---|---|---|---|
| Market Cap | $13,501 | $18,221 | $22,145 | $18,823 |
| - Cash | $33 | $27 | $112 | $571 |
| + Debt | $3,319 | $2,732 | $2,347 | $2,183 |
| Enterprise Value | $16,787 | $20,925 | $24,380 | $20,435 |
| Revenue | $3 | $11 | $2 | -$32 |
| % Growth | -77% | 604.8% | 105% | – |
| Gross Profit | $3 | $9 | -$1 | -$34 |
| % Margin | 100% | 77.8% | -52.8% | 108.1% |
| EBITDA | -$662 | -$419 | -$655 | -$565 |
| % Margin | -26,035.5% | -3,784.3% | -41,693% | 1,791.2% |
| Net Income | -$885 | -$418 | -$732 | -$631 |
| % Margin | -34,808.5% | -3,774.6% | -46,588.9% | 2,000.9% |
| EPS Diluted | -0.003 | -0.002 | -0.003 | -0.003 |
| % Growth | -112.5% | 44.8% | -16% | – |
| Operating Cash Flow | -$553 | -$687 | -$543 | -$242 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$553 | -$687 | -$543 | -$242 |